A primer on tumour immunology and prostate cancer immunotherapy
about
Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review.Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.
P2860
A primer on tumour immunology and prostate cancer immunotherapy
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A primer on tumour immunology and prostate cancer immunotherapy
@ast
A primer on tumour immunology and prostate cancer immunotherapy
@en
A primer on tumour immunology and prostate cancer immunotherapy
@nl
type
label
A primer on tumour immunology and prostate cancer immunotherapy
@ast
A primer on tumour immunology and prostate cancer immunotherapy
@en
A primer on tumour immunology and prostate cancer immunotherapy
@nl
prefLabel
A primer on tumour immunology and prostate cancer immunotherapy
@ast
A primer on tumour immunology and prostate cancer immunotherapy
@en
A primer on tumour immunology and prostate cancer immunotherapy
@nl
P2093
P2860
P3181
P356
P1476
A primer on tumour immunology and prostate cancer immunotherapy
@en
P2093
Charles H Graham
D Robert Siemens
Darrel E Drachenberg
Jasmir G Nayak
Madhuri Koti
Runhan Ren
Thomas Hamilton
P2860
P3181
P356
10.5489/CUAJ.3418
P407
P577
2016-01-01T00:00:00Z